About Open Orphan
Open Orphan is a company based in London (United Kingdom) founded in 2017. The company has 218 employees. Open Orphan has completed 1 acquisition, including CHIMagents. Open Orphan offers products and services including Human Challenge Trials and Laboratory Services. Open Orphan operates in a competitive market with competitors including Altasciences, Ask Gene Pharma, Celerion, MindBio Therapeutics and iCardiac Technologies, among others.
- Headquarter London, United Kingdom
- Employees 218
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website openorphan.com
- Social LinkedIn X Facebook
- Legal Name Open Orphan Plc
- Latest Funding Round$14.66M (USD), Post-IPO
May 2020
- Employee Count218
- Investments & Acquisitions
Products & Services of Open Orphan
Open Orphan offers a comprehensive portfolio of products and services, including Human Challenge Trials and Laboratory Services.
Conducts controlled trials for testing vaccines against infectious diseases.
Provides analytical support for clinical research and drug development.
Funding Insights of Open Orphan
- Total Rounds 2
- Last Round Post-IPO — $14.66M
- First Round $6.92M
(Jan 2020)
All 2 funding rounds of Open Orphan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | $14.66M | Post-IPO | – | – | – |
| Jan 2020 | $6.92M | Post-IPO | – | – | – |
Investments & Acquisitions by Open Orphan
Open Orphan has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CHIMagents.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Potential antiviral drugs and vaccines are manufactured for testing. | chimagents.com | Guildford, United Kingdom | 2019 | Jul 2020 | •••• |
Complete acquisition details for Open Orphan
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Open Orphan
5 dated milestones of Open Orphan across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Open Orphan is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $6.9M.
- Funding Latest funding round, Post-IPO, of $14.7M.
- Acquisition Acquires CHIMagents.
Competitors of Open Orphan
Open Orphan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altasciences, Ask Gene Pharma, Celerion, MindBio Therapeutics and iCardiac Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| altasciences.com | 2015 | Laval, Canada | – | 249 | Early phase clinical research services are provided in North America. | |
| ask-gene.com | 2012 | Camarillo, United States | $20M | 24 | Biosimilars and biosuperiors are developed and commercialized in biotechnology. | |
| celerion.com | 2010 | Lincoln, United States | – | 940 | Early clinical research services are provided for drug development. | |
| mindbiotherapeutics.com | 2021 | Melbourne, Australia | – | – | Provider of phase I & II clinical trial services for mental health diseases | |
| icardiac.com | 2006 | Rochester, United States | $4M | – | Cardiac safety testing and respiratory laboratory services are provided. | |
| avancecro.com | 2018 | Thebarton, Australia | – | – | Clinical development services are provided to pharmaceutical clients worldwide. | |
| spauldingclinical.com | 2007 | West Bend, United States | $1.71M | – | CRO services for Phase I Clinical Trials, and Core ECG lab services for trials from Phase I to IV | |
| awaknlifesciences.com | 2020 | Portishead, United Kingdom | – | 49 | CRO focused on early stage clinical trial research | |
| clerkenwellhealth.com | 2020 | London, United Kingdom | $2.33M | – | CRO focused on conducting early stage clinical development of psychedelic medicines |
Detailed competitors of Open Orphan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Open Orphan
Complete news archive for Open Orphan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Open Orphan
10 companies that operate in the same segment as Open Orphan (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Open Orphan
Open Orphan was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Open Orphan is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Open Orphan has 218 employees.
Open Orphan was founded in 2017 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, where vaccines and antivirals are tested through controlled human challenge studies and clinical trials. Services extend to infectious and respiratory disease research, as well as laboratory support. Contract research organization functions are handled for pharmaceutical clients, supporting drug development processes.
Open Orphan's top competitors include Celerion, Ask Gene Pharma and Altasciences.
Open Orphan offers Human Challenge Trials and Laboratory Services.
Open Orphan has made 1 acquisition, including CHIMagents.
Open Orphan operates through Open Orphan Plc.